Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Antimicrob Resist Infect Control ; 12(1): 129, 2023 11 20.
Article in English | MEDLINE | ID: mdl-37986092

ABSTRACT

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) infections have a significant morbidity and mortality toll. The clinical significance and associated burden of CRE colonization rather than infection state are not frequently investigated. We aimed to assess the outcomes of CRE colonized patients compared to matched controls. METHODS: A secondary analysis of a 1:2 matched case-control study at a tertiary hospital in northern Israel (January-2014 to June-2017). Cases were adults who newly acquired CRE colonization during hospitalization. Controls were inpatients negatively screened for CRE, matched by age, hospitalization division and total days of hospitalization 90 days prior to screening. Our primary outcome was 1-year all-cause mortality. Secondary outcomes included 30-day mortality, diagnosis of any clinical infection, overall days of hospital stay and bloodstream infections all in 1-year follow-up. We estimated crude and propensity score weighted estimates for study outcomes. RESULTS: We included a total of 1019 patients: 340 CRE colonized and 679 non-colonized controls. After adjustment, CRE colonization was not associated with increased 1-year mortality (weighted OR 0.98, 95% CI 0.64-1.50, p = 0.936). CRE colonized patients had 1.7 times the odds of clinical infection of any cause (weighted odds ratio (OR) 1.65, 95% CI 1.06-2.56, p = 0.025). CRE colonized patients had increased length of hospital stay compared to controls (weighted OR 1.52, 95%CI 1.10-2.10, p < 0.001) among 1-year survivors. CONCLUSIONS: CRE colonization may not be independently associated with mortality but with higher risk of clinical infections and longer hospital stays. Infection prevention and antimicrobial stewardship are of utmost importance to prevent acquisition and infections in colonized patients.


Subject(s)
Enterobacteriaceae Infections , Gammaproteobacteria , Adult , Humans , Carbapenems/pharmacology , Carbapenems/therapeutic use , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Case-Control Studies , Enterobacteriaceae Infections/drug therapy , Clinical Relevance
2.
Clin Microbiol Infect ; 29(5): 629-634, 2023 May.
Article in English | MEDLINE | ID: mdl-36641053

ABSTRACT

OBJECTIVES: We aimed to assess the association between carbapenem-resistant Enterobacterales (CRE) colonization pressure and carbapenem exposure and acquisition of carbapenemase-producing Enterobacterales (CPE) and non-carbapenemase-producing carbapenem-resistant Enterobacterales (non-CP-CRE). METHODS: We conducted a parallel 1:2 matched case-control study at Rambam Health Care Campus, Israel, from January 2014 to June 2017. The cases included all adults who acquired CPE or non-CP-CRE in hospital. The controls were hospitalized patients who were negative for CRE on screening and matched by age, hospitalization division and the number of hospitalization days 90 days prior to CRE screening. The exposures of interest were high CRE colonization pressure, defined as a higher-than-median proportion of CRE carriers in the concurrent patient's department before acquisition, and carbapenem exposure, assessed as days of treatment. Conditional logistic regression was used for analyses of CPE and non-CP-CRE. RESULTS: In total, 1058 patients were included: 278 CPE and 75 non-CP-CRE cases, matched to 556 and 149 controls, respectively. High CRE colonization pressure was associated with CPE acquisition (adjusted odds ratio [aOR], 2.6; 95% CI, 1.69-4.02); however, the duration of carbapenem treatment was not (aOR, 1.004; 95% CI, 0.98-1.03; 1-day increment). The duration of carbapenem treatment was significantly associated with non-CP-CRE acquisition (aOR per day, 1.07; 95% CI, 1.03-1.11). A source patient was identified significantly more frequently in epidemiological acquisition investigations of CPE than in those of non-CP-CRE (107/240, 44.6% vs. 18/64, 28.1%, respectively; p 0.017). CONCLUSIONS: CPE acquisition was associated with horizontal transmission, whereas non-CP-CRE was associated with carbapenem exposure. Differences in the drivers of acquisition mandate tailored infection prevention efforts.


Subject(s)
Carbapenem-Resistant Enterobacteriaceae , Enterobacteriaceae Infections , Gammaproteobacteria , Adult , Humans , Case-Control Studies , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae Infections/microbiology , Bacterial Proteins , beta-Lactamases , Enterobacteriaceae , Carbapenems/pharmacology , Carbapenems/therapeutic use , Risk Factors , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use
3.
Rambam Maimonides Med J ; 13(1)2022 Jan 27.
Article in English | MEDLINE | ID: mdl-35089123

ABSTRACT

OBJECTIVE: Israeli hospitals were confronted with a major national outbreak of carbapenemase-producing Enterobacterales (CPE) starting in 2006, caused predominantly by monoclonal Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae. Our hospital, Rambam Health Care Campus (RHCC), was one of the medical centers affected by this outbreak. We aimed to investigate the changing epidemiology of CPE at RHCC since 2006. METHODS: This was a retrospective observational cohort study performed in Northern Israel (Haifa) at RHCC, which is a primary tertiary acute care academic hospital. The study included all patients who had acquired CPE at RHCC between January 2005 and December 2020. RESULTS: The proportion of patients infected with K. pneumoniae dropped from 100% of all CPE in the first years to 28% (37/134) in 2020. In 2014, the carbapenemase in 94% of all CPE patients (89/95) was KPC. This decreased to 56% in 2020, while New Delhi metallo-ß-lactamase (NDM) and OXA-48 carbapenemases increased from 4% and 2% to 29% (39/134) and 12.7% (17/134) of CPE, respectively. CONCLUSIONS: The CPE epidemic evolved from KPC-producing K. pneumoniae to involve different Enterobacterales and carbapenemases. Our results are a microcosm of the current global epidemiology attesting to globalization in bacteriology. The results have implications for infection control and antibiotic treatment of CPE infections.

4.
J Infect Chemother ; 27(10): 1423-1428, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34083145

ABSTRACT

BACKGROUND: To describe the use of wall painting as part of an intervention to control an outbreak of carbapenem-resistant Acinetobacter baumannii (CRAB). METHODS: An interrupted time-series analysis was performed analyzing an intervention in a neurosurgical intensive care unit (NSICU) and an inpatient hematology department in a tertiary level medical center in Israel. The intervention involved wall painting using a water based acrylic paint following patient discharge and terminal cleaning with sodium troclosene as part of an infection control bundle for an outbreak of CRAB in a NSICU and concurrent outbreaks of carbapenem-resistant Enterobacteriaceae (CRE) colonization/infection in the same NSICU and the hematology department. RESULTS: Between January 2013 and December 2018, 122 patients hospitalized in the NSICU were identified with new CRAB colonization/infection. The median incidence in the periods prior to/post intervention were 2.24/1000 HD (interquartile range [IQR] 0.84-2.90/1000) vs. 0/1000 HD (IQR 0-0.49/1000), respectively. Poisson regression indicated a decrease of 92% in the CRAB incidence following the intervention onset (relative risk [RR] 0.080, 95% confidence interval [CI] 0.037-0.174, p < 0.001). Forty-seven patients in the NSICU and 110 in the hematology department were colonized/infected with CRE in the same time period; a significant change was not observed following the start of the intervention in either department (for NSICU RR 1.236, 95% CI 0.370-4.125, p = 0.731; for hematology RR 0.658, 95% CI 0.314-1.378, p = 0.267). CONCLUSIONS: A. baumannii is able to survive on environmental surfaces despite decontamination efforts; wall-painting as part of a bundle may be a successful infection control measure.


Subject(s)
Acinetobacter Infections , Acinetobacter baumannii , Cross Infection , Acinetobacter Infections/drug therapy , Acinetobacter Infections/epidemiology , Acinetobacter Infections/prevention & control , Anti-Bacterial Agents/therapeutic use , Carbapenems/pharmacology , Carbapenems/therapeutic use , Chlorine , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/prevention & control , Disease Outbreaks , Humans , Intensive Care Units , Israel/epidemiology
5.
Am J Infect Control ; 44(9): 1053-4, 2016 09 01.
Article in English | MEDLINE | ID: mdl-27125914

ABSTRACT

The role of health care workers in transmission of carbapenem-resistant Enterobacteriaceae (CRE) has not been evaluated thoroughly. We sought to determine the rate of fecal carriage of CRE among health care workers in our hospital, which is endemic for CRE (prevalence of 19 out of 800 beds and incidence of 128 out of 49,325 hospital admissions). We found no carriers among the 177 health care workers that participated in the study, suggesting that transmission does not occur through personnel gastrointestinal carriage of the bacteria.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Carrier State/epidemiology , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae/drug effects , Health Personnel , beta-Lactam Resistance , Carrier State/microbiology , Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/microbiology , Feces/microbiology , Hospitals , Humans , Incidence , Prevalence , Prospective Studies , Surveys and Questionnaires
6.
Harefuah ; 144(3): 187-90, 230, 2005 Mar.
Article in Hebrew | MEDLINE | ID: mdl-15844458

ABSTRACT

BACKGROUND: The incidence rate of Norovirus gastroenteritis is unknown since diagnostic tests are less readily available than for other agents. This pathogen is identified in less than 10% of acute gastrointestinal illness, despite the fact that recent reports from the United States attribute more than 50% of outbreaks to Noroviruses. OBJECTIVES: This article describes three outbreaks of gastroenteritis caused by Noroviruses in three of Haifa's chronic care hospitals in order to raise awareness of its main role as a common agent in such outbreaks, and thereby include it in the differential diagnosis of outbreak investigations. METHODS: Methods employed included epidemiological investigation of the outbreaks, sanitary inspection, personal interviews of hospital staff members, data collection from medical files and laboratory diagnosis by electron microscopy and RT-PCR of stool and vomitus for Noroviruses. RESULTS: Noroviruses were identified in faeces and vomitus of patients in 2 outbreaks in chronic care hospitals in Haifa. Attack rates were high (20-41%). Proximity in time to these 2 outbreaks, and clinical and epidemiological findings lead us to attribute another outbreak in a third hospital to norovirus as well. CONCLUSIONS: Physicians in institutions and the community should include Noroviruses in the differential diagnosis of outbreaks of gastroenteritis, particularly in cases where no other pathogens have been isolated. Timely requests for identification of Noroviruses are essential. The institution of good hygienic practices is important to prevent spread of this highly infectious agent.


Subject(s)
Caliciviridae Infections/epidemiology , Gastroenteritis/epidemiology , Gastroenteritis/virology , Norovirus , Nursing Homes , Diagnosis, Differential , Disease Outbreaks , Feces/virology , Humans , Israel/epidemiology , Norovirus/genetics , Norovirus/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Vomiting/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...